Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-340
Closed -$5K 757
2022
Q3
$5K Sell
340
-690
-67% -$11.3K ﹤0.01% 881
2022
Q2
$17K Buy
1,030
+10
+1% +$182 ﹤0.01% 684
2022
Q1
$20K Hold
1,020
﹤0.01% 656
2021
Q4
$21K Hold
1,020
﹤0.01% 670
2021
Q3
$19K Buy
1,020
+680
+200% +$12.5K ﹤0.01% 644
2021
Q2
$6K Sell
340
-10
-3% -$171 ﹤0.01% 834
2021
Q1
$6K Hold
350
﹤0.01% 801
2020
Q4
$5K Hold
350
﹤0.01% 716
2020
Q3
$4K Sell
350
-55
-14% -$676 ﹤0.01% 713
2020
Q2
$5K Hold
405
﹤0.01% 669
2020
Q1
$4.8K Sell
405
-1,000
-71% -$15.8K ﹤0.01% 617
2019
Q4
$23.5K Sell
1,405
-50
-3% -$802 ﹤0.01% 556
2019
Q3
$21.9K Buy
+1,455
New +$21.8K ﹤0.01% 631

Other funds holding IX

Evoke Wealth's IX Position: Q4 2022 in Review

Evoke Wealth sold out of ORIX (IX) in Q4 2022, closing a stake of 340 shares — an estimated $5K sold.

Evoke Wealth first reported a position in IX in Q3 2019 and held it in 13 quarters. The position peaked at $23.5K in Q4 2019. 126 funds tracked by Wall St. Rank hold IX as of Q4 2022.

  • Evoke Wealth reported no remaining ORIX position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 340 ORIX shares in Q4 2022, an estimated $5K.
  • Evoke Wealth first reported a position in ORIX in Q3 2019 and held it in 13 quarters.
  • Evoke Wealth's ORIX position peaked at $23.5K in Q4 2019.
  • 126 funds tracked by Wall St. Rank held ORIX as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.